Genometrix
Executive Summary
Genometrix has developed a protoype molecular imaging system it believes can demonstrate single molecule detection at a 10-fold throughput advantage over conventional technologies used in sequence-, hybridization-, and amplification-based DNA research and diagnostics protocols.
You may also be interested in...
GE-Genometrix: Dx Imaging Meets Genomics
In an intriguing deal, GE Medical Systems, one of the largest suppliers of MRI and PET equipment, is teaming up with Genometrix, Inc., an applied genomics company in a research collaboration that will combine molecular imaging techniques with genetic probes to develop technologies for detecting and quantifying risk levels for diseases such as breast and prostate cancer.
Chinese Companies Progress Peptide Fusion Inhibitors For COVID-19
China's Hybio, Youcare and Shanxi Jinbo appear to be the only three companies in the world trying to develop a fusion inhibitor for COVID-19, the most advanced of which has now moved into a domestic Phase II trial.
J&J’s Talc Subsidiary Not ‘Financially Distressed’ Enough For Bankruptcy – Third Circuit
The J&J company holding the firm’s liabilities relating to talc litigation, which declared bankruptcy in 2021 shortly after its formation, had its Chapter 11 petition denied by the Third Circuit on 30 January. Attorneys weigh in on the implications for J&J and wider industry.